The European market represents a major opportunity for developers of blood pressure (BP) monitoring technology, but with great opportunity comes great scrutiny. Navigating the path to CE marking under the EU’s rigorous Medical Device Regulation (MDR 2017/745) requires a level of preparation and precision. Success now hinges on providing a higher caliber of clinical evidence, more robust post-market surveillance plans, and more comprehensive technical documentation than ever b